The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
pitavastatin calcium
pitavastatin calcium · PITAVASTATIN CALCIUM 4 mg/1 · Tablet, Film Coated · Oral · XLCare Pharmaceuticals Inc.
NDC 72865-0293-90 · 90 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for pitavastatin calcium (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Evaric Pharmaceuticals IncUnited Statesmanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA205977
- TE code
- AB
- Approval date
- Apr 30, 2024
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of pitavastatin calcium (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AvKARE | PITAVASTATIN CALCIUM 4.18 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvKARE | PITAVASTATIN CALCIUM 1.045 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvKARE | PITAVASTATIN CALCIUM 2.09 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | PITAVASTATIN CALCIUM 1.045 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | PITAVASTATIN CALCIUM 4.18 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | PITAVASTATIN CALCIUM 2.09 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Kowa Pharmaceuticals America, Inc. | PITAVASTATIN CALCIUM 4.18 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Kowa Pharmaceuticals America, Inc. | PITAVASTATIN CALCIUM 2.09 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Kowa Pharmaceuticals America, Inc. | PITAVASTATIN CALCIUM 1.045 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar RxLLC | PITAVASTATIN CALCIUM 2.09 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar RxLLC | PITAVASTATIN CALCIUM 4.18 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals, Inc. | PITAVASTATIN CALCIUM 4.18 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals, Inc. | PITAVASTATIN CALCIUM 1.045 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals, Inc. | PITAVASTATIN CALCIUM 2.09 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| XLCare Pharmaceuticals Inc. | PITAVASTATIN CALCIUM 4 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| XLCare Pharmaceuticals Inc. | PITAVASTATIN CALCIUM 2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| XLCare Pharmaceuticals Inc. | PITAVASTATIN CALCIUM 1 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "pitavastatin calcium — NDC 72865-0293-90," retrieved September 3, 2026, https://drugdashboards.com/drug/72865029390.
Free to cite with attribution — see how the data is put together.